Matthew Davenport Hill

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

High Impact

CEO

Arkansas State University primary UA Fort Smith

Also affiliated: Los Alamos National Laboratory (2021–2022); Ohio Northern University (2017–2019); Central Michigan University (2020); University of Mississippi (2008–2013); Bristol-Myers Squibb (United States) (2010–2022); National Council for Voluntary Organisations (2015–2016); Natera (United States) (2011–2018); Sage Therapeutics (United States) (2022); Accenture (United Kingdom) (2001); University of Southampton (2015); Indiana University School of Medicine (2020); University of Southern Mississippi (2014); Massachusetts Institute of Technology (2006–2010); Elizabeth City State University (2018–2022); UConn Health (2015); Columbia University (2014–2015); Stanford University (2009–2015)

37 h-index 178 pubs 10,186 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website Research Group

OverviewAI-generated summary

Matthew D. Hill's research program investigates novel therapeutic targets and strategies for complex diseases. His work includes the development of SAGE-718, a first-in-class N-methyl-D-aspartate receptor positive allosteric modulator with potential applications in treating cognitive impairment. He has also focused on the development of BET inhibitors as potential cancer treatments, exploring new chemotypes and optimizing pharmacokinetic properties to enhance efficacy.

Further research areas include strategic planning for transforming pancreatic cancer care through interdisciplinary roadmaps and investigating the dynamics of corporate cash holdings and liquidity management. Hill's scholarship is recognized by a high-impact researcher designation, with 181 total publications and over 9,446 citations, reflected in an h-index of 33. He actively leads a research group and maintains an active lab website, collaborating with researchers such as Katie Hill at Arkansas State University.

Metrics

h-index: 37
Publications: 178
Citations: 10,186

Positions

CEO 2025–present

Retuned Therapeutics Inc ORCID
CEO publications 2009–2025

Arkansas State University ORCID

Selected Publications

Liquidity Management and Gender: Evidence from U.S. Households (2025)

Atlantic Economic Journal DOI OpenAlex
The Persistent Rise in Corporate Cash Holdings (2025)

Atlantic Economic Journal DOI OpenAlex
An Investigation of Trades That Move the BBO Using Strings (2025)

Journal of risk and financial management DOI OpenAlex
Advertising’s Monetary Contribution to Shareholder Value (2020)

Marketing Management Journal DOI OpenAlex
Do market share and demand uncertainty influence the relation between advertising expenditures and shareholder value? (2020)

Journal of Business Research 18 citations DOI OpenAlex
Operating performance and aggressive trade credit policies (2018)

Journal of Banking & Finance 90 citations DOI OpenAlex
Determinants of REIT Credit Ratings (2018)

Journal of Real Estate Portfolio Management 2 citations DOI OpenAlex
Trade Credit or Financial Credit? An International Study of the Choice and Its Influences (2017)

Emerging Markets Finance and Trade 41 citations DOI OpenAlex